𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study

✍ Scribed by Alessandra Fabi; Giulio Metro; Antonello Vidiri; Gaetano Lanzetta; Mariantonia Carosi; Stefano Telera; Marta Maschio; Michelangelo Russillo; Isabella Sperduti; Carmine M. Carapella; Francesco Cognetti; Andrea Pace

Publisher
Springer US
Year
2010
Tongue
English
Weight
319 KB
Volume
100
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase I study of temozolomide and escala
Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma
✍ David N. Korones; Michal Benita-Weiss; Thomas E. Coyle; Laszlo Mechtler; Peter B πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 74 KB

## Abstract ## BACKGROUND Although temozolomide is active against recurrent malignant glioma, responses in many patients are modest and short‐lived. Temozolomide may prove more effective in combination with other agents. Therefore, combination oral chemotherapy for these patients is a particularly

Phase II evaluation of high-dose intrave
Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure
✍ Alexander M. Spence; Mitchel S. Berger; Robert B. Livingston; Francis Ali-Osman; πŸ“‚ Article πŸ“… 1992 πŸ› Springer US 🌐 English βš– 347 KB

Twenty-one patients with recurrent malignant glioma who had failed prior chemotherapy with nitrosoureas were treated with high-dose intravenous cisplatin on days 1 and 8 of successive 4 week cycles. Fourteen patients were evaluable for response. Four patients showed partial responses; mean time to t